According to information gathered recently by Cutting Edge Information, an intelligence leader in the pharmaceutical industry, the responsibility for paying expensive prescription drugs is falling more frequently upon health insurance subscribers than on insurance companies. These health insurance providers are shifting the rising cost of prescription drugs to their members, leaving many people unable to afford the prescriptions they need for treatment. Many people will choose the generic alternative, or simply go without, leaving the leading name brand companies struggling in what is normally a recession proof industry. If people are unable to pay for name brand prescriptions and are choosing to go for generic, or go without, how will this affect the pharmacuetical industry and the further research and development of prescription drugs in this country?